S
54.43
-4.18 (-7.13%)
| 前收盘价格 | 58.61 |
| 收盘价格 | 59.16 |
| 成交量 | 4,575,718 |
| 平均成交量 (3个月) | 1,575,073 |
| 市值 | 5,281,457,152 |
| 市盈率 (P/E TTM) | 23.26 |
| 预期市盈率 (P/E Forward) | 6.80 |
| 价格/销量 (P/S) | 3.09 |
| 股市价格/股市净资产 (P/B) | 3.46 |
| 52周波幅 | |
| 利润日期 | 29 Apr 2025 - 5 May 2025 |
| 营业毛利率 | 12.37% |
| 营业利益率 (TTM) | 24.56% |
| 稀释每股收益 (EPS TTM) | 2.34 |
| 季度收入增长率 (YOY) | 65.90% |
| 季度盈利增长率 (YOY) | 248.40% |
| 总债务/股东权益 (D/E MRQ) | 87.90% |
| 流动比率 (MRQ) | 4.20 |
| 营业现金流 (OCF TTM) | -205.79 M |
| 杠杆自由现金流 (LFCF TTM) | -445.48 M |
| 资产报酬率 (ROA TTM) | 3.77% |
| 股东权益报酬率 (ROE TTM) | 19.71% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Sarepta Therapeutics, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
1.5
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | -2.5 |
| 平均 | 1.50 |
|
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Mid Core |
| 内部持股比例 | 4.41% |
| 机构持股比例 | 92.27% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 183.00 (Needham, 236.21%) | 购买 |
| 中 | 107.00 (96.58%) | |
| 低 | 75.00 (HC Wainwright & Co., 37.79%) | 保留 |
| 平均值 | 123.00 (125.98%) | |
| 总计 | 4 购买, 4 保留 | |
| 平均价格@调整类型 | 63.79 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Morgan Stanley | 11 Apr 2025 | 182.00 (234.37%) | 购买 | 51.03 |
| Wells Fargo | 11 Apr 2025 | 115.00 (111.28%) | 购买 | 51.03 |
| HC Wainwright & Co. | 07 Apr 2025 | 75.00 (37.79%) | 保留 | 52.40 |
| 04 Apr 2025 | 75.00 (37.79%) | 保留 | 54.43 | |
| Needham | 03 Apr 2025 | 183.00 (236.21%) | 购买 | 58.61 |
| 18 Mar 2025 | 202.00 (271.12%) | 购买 | 73.54 | |
| RBC Capital | 31 Mar 2025 | 87.00 (59.84%) | 保留 | 63.82 |
| 27 Feb 2025 | 161.00 (195.79%) | 购买 | 103.06 | |
| Scotiabank | 20 Mar 2025 | 80.00 (46.98%) | 保留 | 73.45 |
| 07 Mar 2025 | 105.00 (92.91%) | 保留 | 103.03 | |
| Cantor Fitzgerald | 19 Mar 2025 | 163.00 (199.47%) | 购买 | 79.97 |
| 18 Mar 2025 | 163.00 (199.47%) | 购买 | 73.54 | |
| Deutsche Bank | 19 Mar 2025 | 99.00 (81.88%) | 保留 | 79.97 |
| 显示更多 | ||||
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合